We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Pregnancy in SARDs: main issues
- Maternal disease and pregnancy
- Pregnancy in SARDs: different problems
- Outline of presentation (1)
- Discuss family planning
- Family planning includes contraception
- Differences in maternal & child risks in SARDs
- Planning a pregnancy – assess the risk
- Risk stratification in preconception counselling
- Risk stratification for mother and child
- The case of rheumatoid arthritis (RA)
- RA algorithm
- RA pregnancy planning
- Auto-antibodies are risks for the pregnancy
- Who should postpone or not become pregnant?
- Outline of presentation (2)
- Pregnancy monitoring
- Laboratory monitoring – pregnancy physiology
- Fetal surveillance during pregnancy
- Outline of presentation (3)
- Therapy before/during pregnancy
- Drugs before/during pregnancy?
- Corticosteroids
- Corticosteroids in pregnancy
- Antirheumatic drugs & pregnancy & lactation (1)
- Antirheumatic drugs & pregnancy & lactation (2)
- Transplacental passage of TNF inhibitors
- Lack of placental transfer of certolizumab pegol
- Antirheumatic drugs & pregnancy & lactation (3)
- Bisphosphonates in pregnancy
- Anticoagulants in pregnancy
- Flare of connective tissue disease in pregnancy
- Take home messages (1)
- Possible risks at delivery
- Outline of presentation (4)
- Rheumatic disease post partum
- Drugs compatible with breastfeeding (1)
- Drugs compatible with breastfeeding (2)
- bDMARDs and breastfeeding
- Drugs to be avoided during breastfeeding
- Take home messages (2)
Topics Covered
- Fertility in women with systemic autoimmune rheumatic disease (SARD)
- Disease control and pregnancy management
- Pregnancy risk profiling
- Strict and multidisciplinary pregnancy monitoring
- Therapy tuned to disease and drugs allowed during pregnancy
- Post-partum monitoring as an additional step
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Meroni, P.L. (2019, January 31). Pregnancy in rheumatic diseases [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 5, 2024, from https://doi.org/10.69645/ATYH2323.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Pier Luigi Meroni has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Gynaecology & Obstetrics
Transcript
Please wait while the transcript is being prepared...
0:00
The old dogma that pregnancy is not allowed in rheumatic diseases is now broken.
0:09
Rheumatic diseases are more frequent in women of
the child-bearing age and fertility is not reduced in these women.
So, it's not surprising that the wish for pregnancies is becoming more and more popular.
This is true, also, because of the prognosis of
the rheumatic diseases has improved in the last years.
Moreover, the old contraindication for pregnancy because of
the possible transmission of
the disease from the mother to the baby in a genetic manner is no more acceptable,
since we know that if it's true that systemic rheumatic diseases are genetically determined,
they are not usually transmitted in a direct manner to the baby.
1:03
Addressing pregnancy in rheumatic diseases,
we not only have to take into account the effect of
pregnancy on the maternal disease, but we have to also
look at the other side of the coin, taking into
account the effect of the maternal disease on the pregnancy,
and in particular, the effect of the treatment of the mother on the offspring.
1:29
Problems for pregnancy in
rheumatic diseases are different depending on different diseases.
For example, women with rheumatoid arthritis
usually, display flares in pregnancy up to 20 percent.
So, they're relatively rare.
Even though they are rare, there are also risks for complications,
which can be found particularly in women with a very active disease.
This is true also for the risk for the babies.
On the other hand,
systemic lupus erythematosus women,
as well as other connective tissue diseases,
can display flares in pregnancy in up to 50 percent of the cases.
The risk for complications is important and includes miscarriages, or pre-eclampsia,
prematurity for the mothers,
or intrauterine growth retardation, prematurity, and neonatal lupus for babies.